Wearable Drug Delivery Position Cam Med Inc as Qlibrium, a pioneer in flexible on-body drug delivery platforms. Opportunities exist to partner with pharma and contract manufacturers seeking discreet, patient-friendly subcutaneous delivery solutions.

Early Stage Revenue Current revenue is under one million, indicating a small but potentially high-growth target for collaboration, licensing, or co-development deals with larger medical device firms or pharmaceutical companies seeking integrated delivery systems.

Strategic Partnerships Leverage recognition as MassChallenge Gold Winner and MedTech Innovator Top 100 to approach enterprise partners and attract interest from corporate accelerators or joint ventures looking for innovative on-body platforms.

Scale via OEM With a lean team and a defined platform, explore origination of OEM manufacturing partnerships, white-label opportunities, or licensing of QForma technology to established medical device manufacturers seeking to add on-body delivery capabilities.

Market Readiness Target pharmaceutical sponsors aiming to replace or augment existing subcutaneous injections with wearable systems, addressing market trends toward patient convenience, adherence, and remote monitoring; emphasize regulatory-friendly, flexible deployment.